However, the partially abolished R5 inhibition efficacy on cell migration and invasion that occurs with TGF-β1 treatment suggests that specific blocking of Slit2/Robo1 signaling to inhibit tumor metastasis using R5 could also target other signaling pathways, at least including activation of Hakai-mediated EMT [8]. Here, SLIT2 is linked to neoplasm.